Medication Adherence in the MTA: Saliva Methylphenidate Samples Versus Parent Report and Mediating Effect of Concomitant Behavioral Treatment

 The work reported was supported by cooperative agreement grants and contracts from the National Institute of Mental Health to the following: University of California, Berkeley: U01 MH50461 and N01MH12009; Duke University: U01 MH50477 and N01MH12012; University of California, Irvine: U01 MH50440 and N01MH 12011; Research Foundation for Mental Hygiene (New York State Psychiatric Institute/Columbia University): U01 MH50467 and N01 MH12007; Long Island-Jewish Medical Center U01 MH50453; New York University: N01MH 12004; University of Pittsburgh: U01 MH50467 and N01 MH 12010; and McGill University N01MH12008. The Office of Special Education Programs of the U.S. Department of Education and the Office of Juvenile Justice and Delinquency Prevention of the Justice Department also participated in funding.The opinions and assertions contained in this article are the private views of the authors and are not to be construed as official or as reflecting the views of the National Institute of Mental Health, the National Institutes of Health, or the Department of Health and Human Services.This article is the subject of an editorial by Dr. Philip L. Hazell in this issue.Clinical trial registration information—The NIMH MTA Study. URL: http://www.clinicaltrials.gov. Unique identifier: NCT00000388.

PII: S0890-8567(09)60067-8

doi: 10.1097/CHI.0b013e31819c23ed

© 2009 American Academy of Child and Adolescent Psychiatry. Published by Elsevier Inc. All rights reserved.